What is the ticker symbol for BioMarin Pharmaceutical Inc.?

BioMarin Pharmaceutical Inc. trades as BMRN on the NASDAQ.

What are BioMarin Pharmaceutical Inc.'s marketed drugs?

Top marketed products include Rhgalns, Aryplase, Aldurazyme, Kuvan, Rhttp1, Roctavian.

NASDAQ 6 marketed ·

Ticker	BMRN (NASDAQ)

Rhgalns · Metabolic · revenue 500
VIMIZIM provides exogenous N-acetylgalactosamine-6-sulfatase to increase the catabolism of GAGs KS and C6S in lysosomes.
Aryplase · Metabolic · revenue 400
Aryplase breaks down accumulated glycosaminoglycans in lysosomes to treat Maroteaux-Lamy syndrome.
Aldurazyme · Metabolic · revenue 300
Aldurazyme breaks down abnormal sugar molecules in the body to treat Mucopolysaccharidosis I.
Kuvan · Oncology · revenue 300
Kuvan works by activating the enzyme Phenylalanine Hydroxylase to break down phenylalanine.
Rhttp1 · Neuroscience
Cerliponase alfa works by inhibiting the breakdown of a protein called tripeptidyl peptidase, which is deficient in patients with late-infantile neuronal ceroid lipofuscinosis.
Roctavian · Rare Disease
Roctavian introduces a functional copy of the F8 gene into cells to produce factor VIII protein.

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: